Drug-induced receptor occupancy: substantial differences in measurements made in vivo vs ex vivo

被引:24
作者
Kapur, S
Barlow, K
VanderSpek, SC
Javanmard, M
Nobrega, JN
机构
[1] CAMH, Schizophrenia Program, Clarke Div, Toronto, ON M5T 1R8, Canada
[2] CAMH, PET Ctr, Clarke Div, Toronto, ON M5T 1R8, Canada
[3] CAMH, Neuroimaging Res Sect, Toronto, ON M5T 1R8, Canada
[4] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[5] Univ Toronto, Dept Psychol & Pharmacol, Toronto, ON, Canada
基金
英国医学研究理事会;
关键词
receptor occupancy; in vivo; ex vivo; raclopride;
D O I
10.1007/s002130100790
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: The number of receptors occupied by a given drug is a central construct in understanding drug action in the brain. Two techniques have been commonly used to measure drug receptor occupancy. In one method, the drug and the radioligand used to measure occupancy compete in vivo while in the other method, the drug is injected into the living animal, the animal killed and the radioligand competes for available receptors ex vivo. While these methods are often used interchangeably, there has been no systematic comparison of their sensitivities and consistency. Objectives. In this study, we performed a systematic within-animal comparison of drug-induced receptor occupancy as measured by the in vivo vs the ex vivo methods. Methods: We examined the occupancy of dopamine D-2 receptors by different doses of the drug raclopride using the in vivo and and ex vivo autoradiographic methods in the same rat with C-11-raclopride and H-3-raclopride as radioligands, respectively. Results: The in vivo method showed a significantly greater sensitivity and internal consistency while the ex vivo method was less sensitive, and increasingly so as a function of longer incubation times. The lack of sensitivity was accounted for by the unidirectional, dissociation of the drug from the receptors in the incubation medium. Conclusions: Our-data suggest that these two methods are not interchangeable; the ex. vivo method is much less sensitive, lacks internal consistency and hence is best avoided.
引用
收藏
页码:168 / 171
页数:4
相关论文
共 15 条
[1]  
FARDE L, 1992, ARCH GEN PSYCHIAT, V49, P538
[2]  
Funakoshi T, 1999, RES COMMUN MOL PATH, V105, P35
[3]   Dopamine D3 receptor binding by D3 agonist 7-OH-DPAT (7-hydroxy-dipropylaminotetralin) and antipsychotic drugs measured ex vivo by quantitative autoradiography [J].
Kaichi, Y ;
Nonaka, R ;
Hagino, Y ;
Watanabe, M .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2000, 78 (01) :7-11
[4]  
Kapur S, 2000, J PSYCHIATR NEUROSCI, V25, P161
[5]   Relationship between dopamine D2 occupancy, clinical response, and side effects:: A double-blind PET study of first-episode schizophrenia [J].
Kapur, S ;
Zipursky, R ;
Jones, C ;
Remington, G ;
Houle, S .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (04) :514-520
[6]  
Kenakin T., 1997, Pharmacologic analysis of drug-receptor interaction, Vthird
[7]   SPECIFIC INVITRO AND INVIVO BINDING OF H-3-RACLOPRIDE - A POTENT SUBSTITUTED BENZAMIDE DRUG WITH HIGH-AFFINITY FOR DOPAMINE D-2 RECEPTORS IN THE RAT-BRAIN [J].
KOHLER, C ;
HALL, H ;
OGREN, SO ;
GAWELL, L .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (13) :2251-2259
[8]   Comparison of methods for analysis of clinical [C-11]raclopride studies [J].
Lammertsma, AA ;
Bench, CJ ;
Hume, SP ;
Osman, S ;
Gunn, K ;
Brooks, DJ ;
Frackowiak, RSJ .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1996, 16 (01) :42-52
[9]  
LIMBIRD LE, 1986, CELL SURFACE RECEPTO
[10]   Paroxetine binding to the rat norepinephrine transporter in vivo [J].
Owens, MJ ;
Knight, DL ;
Nemeroff, CB .
BIOLOGICAL PSYCHIATRY, 2000, 47 (09) :842-845